Cidara Therapeutics Inc (CDTX)

01:50 AM

Contrasting Cidara Therapeutics (NASDAQ:CDTX) and Kodiak Sciences (NASDAQ:KOD) - Defense World

01:50 AM

Jan 18, 2025

Here’s Why Cidara Therapeutics, Inc. (CDTX) Is Skyrocketing - MSN

Jan 18, 2025

Jan 14, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Short Interest Update - MarketBeat

Jan 14, 2025

Jan 13, 2025

Why These 24 Stocks Are Skyrocketing - Insider Monkey

Jan 13, 2025

Jan 12, 2025

Geode Capital Management LLC Buys 9,771 Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World

Jan 12, 2025

Jan 09, 2025

(CDTX) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Jan 09, 2025

Jan 09, 2025

Cidara Therapeutics (NASDAQ:CDTX) Shares Cross Above 50 Day Moving AverageTime to Sell? - MarketBeat

Jan 09, 2025

Jan 08, 2025

Cidara Therapeutics announces board changes, CMO separation - Investing.com

Jan 08, 2025

Jan 08, 2025

Cidara Therapeutics Announces Leadership Changes and Appointments - MSN

Jan 08, 2025

Jan 07, 2025

Cidara Therapeutics, Inc. Announces Management Changes - Marketscreener.com

Jan 07, 2025

Jan 06, 2025

Aspergillosis Market Expected to rise, 2034 | Regeneron, Pulmocide, Astellas Pharma, Cipla, Pulmatrix, F2G, Cellix Bio, SCYNEXIS, TFF, Matinas BioPharma, Amplyx Pharmaceuticals, Cidara Therapeutics, I - The Globe and Mail

Jan 06, 2025

Dec 31, 2024

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives $32.20 Average PT from Analysts - Defense World

Dec 31, 2024

Dec 30, 2024

Cidara Therapeutics stock soars to 52-week high of $24.99 By Investing.com - Investing.com Nigeria

Dec 30, 2024

Dec 30, 2024

Cidara Therapeutics stock soars to 52-week high of $24.99 - Investing.com

Dec 30, 2024

Dec 29, 2024

(CDTX) Proactive Strategies - Stock Traders Daily

Dec 29, 2024

Dec 28, 2024

Analysts Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) PT at $32.20 - MarketBeat

Dec 28, 2024

Dec 24, 2024

Influenza A Infections Market Overview: Size, Share, and Future - openPR

Dec 24, 2024

Dec 23, 2024

Cidara Therapeutics files to sell 7.04M shares of common stocks by selling shareholders - MSN

Dec 23, 2024

Dec 19, 2024

Long Term Trading Analysis for (CDTX) - Stock Traders Daily

Dec 19, 2024

Dec 19, 2024

Cidara Therapeutics (CDTX) Just Flashed Golden Cross Signal: Do You Buy? - MSN

Dec 19, 2024

Dec 17, 2024

Cidara Therapeutics stock soars to 52-week high of $24.4 - Investing.com

Dec 17, 2024

Dec 17, 2024

Cidara Therapeutics (NASDAQ:CDTX) versus Ginkgo Bioworks (NYSE:DNA) Financial Survey - Defense World

Dec 17, 2024

Dec 16, 2024

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Sees Large Increase in Short Interest - MarketBeat

Dec 16, 2024

Dec 15, 2024

Cidara Therapeutics (NASDAQ:CDTX) Coverage Initiated at Royal Bank of Canada - Defense World

Dec 15, 2024

Dec 14, 2024

RBC Capital Initiates Coverage of Cidara Therapeutics (CDTX) with Outperform Recommendation - MSN

Dec 14, 2024

Dec 13, 2024

Cidara Therapeutics (NASDAQ:CDTX) Now Covered by Analysts at Royal Bank of Canada - MarketBeat

Dec 13, 2024

Dec 05, 2024

Cidara achieves full enrolment in influenza prevention trial - Yahoo Finance

Dec 05, 2024

Dec 05, 2024

RA Capital Management L.P. Takes $7.56 Million Position in Cidara Therapeutics, Inc. (NASDAQ:CDTX) - MarketBeat

Dec 05, 2024

Dec 04, 2024

Cidara Therapeutics Completes Enrollment of Phase 2b - GlobeNewswire

Dec 04, 2024

Dec 04, 2024

Cidara Achieves Major Milestone: 5,000 Patients Enrolled in Game-Changing Universal Flu Prevention Trial - StockTitan

Dec 04, 2024

Dec 03, 2024

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of "Buy" from Analysts - MarketBeat

Dec 03, 2024

Dec 02, 2024

Finance Watch: PIPEs Still Key Even As FOPO Fundraising Climbs - Citeline News & Insights

Dec 02, 2024

Nov 27, 2024

(CDTX) Trading Report - Stock Traders Daily

Nov 27, 2024

Nov 26, 2024

RA CAPITAL MANAGEMENT, L.P. Increases Stake in Cidara Therapeuti - GuruFocus.com

Nov 26, 2024

Nov 23, 2024

ATB’s €54M series A among largest ever in Belgium - BioCentury

Nov 23, 2024

Nov 22, 2024

Cidara Therapeutics announces $105 million private placement By Investing.com - Investing.com South Africa

Nov 22, 2024

Nov 21, 2024

Cidara Therapeutics announces $105 million private placement - Investing.com India

Nov 21, 2024

Nov 21, 2024

Cidara: Potential To Change Flu Prophylaxis Landscape With CD388 - Seeking Alpha

Nov 21, 2024

Nov 21, 2024

Cidara to raise up to $105 million in private placement - The Pharma Letter

Nov 21, 2024

Nov 21, 2024

Cidara Therapeutics shares surge on $105M equity private placement - MSN

Nov 21, 2024

Nov 21, 2024

Cidara Therapeutics Shares Surge 26% on $105 Mln Private Placement - MarketWatch

Nov 21, 2024

Nov 21, 2024

Cidara Therapeutics Announces $105 Million Private Placement - GlobeNewswire

Nov 21, 2024

Nov 21, 2024

Cidara Therapeutics Secures $105M Private Placement Led by Venrock Healthcare | CDTX Stock News - StockTitan

Nov 21, 2024

Nov 19, 2024

Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference - GlobeNewswire

Nov 19, 2024

Nov 19, 2024

Cidara Therapeutics CEO to Present at Evercore HealthCONx Conference | CDTX Stock News - StockTitan

Nov 19, 2024

Nov 17, 2024

(CDTX) Technical Data - Stock Traders Daily

Nov 17, 2024

Nov 14, 2024

HC Wainwright Has Positive Outlook of CDTX FY2024 Earnings - MarketBeat

Nov 14, 2024

Nov 11, 2024

Cidara Therapeutics (NASDAQ:CDTX) Given Buy Rating at HC Wainwright - MarketBeat

Nov 11, 2024

Nov 08, 2024

Analysts Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) PT at $29.67 - MarketBeat

Nov 08, 2024